Published July 10, 2021 | Version v1
Journal article Open

Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms

  • 1. Functional Pharmacology Unit, Department of Neuroscience, Uppsala University, Uppsala, Sweden

Description

Several neurological symptoms and complications have been described in association with COVID-19, such as anosmia, ageusia, encephalitis and Guillain-Barr´e syndrome. Here, we review the literature describing SARSCoV-2-induced neurological manifestations and provide a comprehensive discussion of proposed mechanisms underlying the neurological pathophysiology. First, we analyse the neuroinvasiveness potential of the coronavirus family based on previous SARS-CoV-1 studies. Then, we describe the current evidence on COVID-19- induced nervous tissue damage, including processes behind brain vasculopathy and cytokine storm. We also discuss in detail anosmia and Guillain-Barr´e syndrome. Finally, we provide a summarised timeline of the main findings in the field. Future perspectives are presented, and suggestions of further investigations to clarify how SARS-COV-2 can affect the CNS.

Files

Johansson_Covid19_2021.pdf

Files (8.8 MB)

Name Size Download all
md5:5b827dfd6572d16e7a0b67728a48eca5
8.8 MB Preview Download

Additional details

Funding

European Commission
FAT4BRAIN - Networking for excellence in functional pharmacology to study the role of fatty acid metabolism in neurological disorders 857394